You've noticed the afternoon crash, the flat workouts, the drive that isn't quite there. A basic panel came back "low normal" with a shrug — and now you're trying to figure out a path that helps you feel like yourself without closing a door you might want open later.
This article is educational and not medical advice. Any decision about treatment is made by an independent, licensed provider based on your labs, history, and goals.
First, why the fertility question is real
Testosterone therapy (TRT) works by adding testosterone from the outside. Your brain reads that as "we have enough" and dials down the signals that tell your testes to keep working — luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Because FSH is central to sperm production, exogenous testosterone can suppress sperm counts, sometimes to zero, while a man is on it [1][2]. This effect has been studied enough that testosterone was even evaluated as a candidate for male contraception [2].
For a man who plans to start a family in a few years, that's the crux. TRT can be effective at raising serum testosterone, but the tradeoff on fertility is not a rumor — it's a documented mechanism [1][2].
Enclomiphene approaches the problem from the opposite direction. It is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus and pituitary, which tends to *increase* the body's own LH and FSH — and, in turn, its own testosterone production [3][4]. Because the testes stay in the loop, this class of medication is generally studied for men who want to preserve the machinery of fertility while addressing low testosterone [3][4].
The two paths, side by side
Think of it less as "which is better" and more as "which fits your next few years."
Testosterone therapy (TRT) replaces the hormone directly. The Endocrine Society's clinical practice guideline recommends testosterone therapy for men with consistent symptoms *and* unequivocally low testosterone confirmed on more than one morning measurement — not a single borderline number [1]. Notably, the same guideline advises *against* starting testosterone in men planning fertility in the near term [1].
Enclomiphene keeps your own signaling active. It is generally discussed as an oral option for younger men with secondary hypogonadism who want to keep fertility open [3][4]. Reversibility is a defining feature: because it stimulates rather than replaces, stopping the medication is expected to return the axis toward its prior state [3].
Important caveat on availability: enclomiphene is not currently marketed as a stand-alone FDA-approved product, so when it is used it is often compounded. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Source: [1] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline, [2] Male hormonal contraception: suppression of spermatogenesis by testosterone (WHO/multicenter studies review), [3] Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial
What a provider actually confirms before anything
A "low normal" from urgent care is a starting point, not a diagnosis. Low testosterone is defined by *repeated* morning measurements plus symptoms, not one draw [1]. A careful workup typically looks at:
- Total and free testosterone, measured in the morning, more than once [1].
- LH and FSH — these tell the provider whether the problem is at the testes (primary) or the brain's signaling (secondary), which shapes the whole conversation [1].
- Estradiol, prolactin, and sometimes SHBG for context [1].
- A baseline semen analysis if fertility is a stated priority — because you can't protect what you never measured.
- Hematocrit and a PSA conversation where appropriate, since testosterone therapy can raise red blood cell counts and requires monitoring over time [1].
That monitoring point matters for both readers here. TRT is not a set-and-forget prescription. The Endocrine Society recommends checking testosterone levels and hematocrit at baseline and during treatment, because elevated hematocrit (erythrocytosis) is a recognized risk that a provider watches for [1]. "Someone who owns the plan and adjusts it" isn't a nice-to-have — it's the standard of care.
Source: [1] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
Reading the numbers without the hype
When your PCP says "you're fine," they may be reading a wide reference range. The FDA-recognized framing and society guidance treat diagnosis as a combination of symptoms plus confirmed low readings — which is exactly why a single number rarely tells the story [1][5]. A provider's job is to interpret the pattern, not one dot on a lab sheet.
And neither path is a personality upgrade or a guarantee. What a provider can offer is a structured way to confirm what's actually going on, match it to your timeline, and monitor it honestly.
morning measurements · marker = Guideline: confirm on ≥2 mornings
Source: [1] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
If you're closer to Marcus's situation
If children are on the horizon and the labs are borderline, the conversation a provider walks through usually centers on *keeping options open first*. That's the entire logic of a reversible, fertility-sparing approach: address the signaling and preserve the machinery, with a baseline semen analysis on file so nothing is guessed [3][4]. If the numbers don't truly meet criteria, the honest answer might be lifestyle and re-testing — and a good provider will say that plainly.
If you're closer to Greg's situation
If low testosterone is genuinely confirmed and family planning isn't the immediate priority, the discussion can be broader — including testosterone therapy, with a clear-eyed talk about it being an ongoing commitment that requires monitoring [1]. The "lose weight first" advice isn't wrong that body composition and testosterone are linked, but it's incomplete when low energy is the very thing making change hard. A provider can hold both truths and build an actual plan.
The honest bottom line
- TRT replaces testosterone and can suppress fertility while used [1][2].
- Enclomiphene stimulates your own production and is generally studied as fertility-sparing and reversible [3][4].
- Either way, diagnosis requires repeated morning labs plus symptoms, and treatment requires ongoing monitoring [1].
- A prescription is never guaranteed; it's a decision an independent licensed provider makes with you.
Where Velri fits
Velri is a technology and coordination company — not a medical practice. We help you get the right labs drawn, connect you with an independent, licensed provider who can review your results and history, and — *only if that provider decides it's appropriate* — coordinate with a licensed pharmacy for fulfillment. We don't diagnose, we don't prescribe, and we don't promise any outcome. What we do is remove the friction between "something feels off" and "a physician who takes your goals — including keeping fertility open — seriously."
This content is educational and is not medical advice, diagnosis, or a recommendation for any specific medication.
